PRNewswire · Jul 2026
Synapticure launched a virtual ataxia care program and partnered with Biogen to support awareness; the program expands its virtual neurology offering beyond ALS, Parkinson's, Alzheimer's/dementia, and Huntington's disease.
We deliver personalized medicine for neurodegenerative patients
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Synapticure is a Chicago-based, remote-first virtual neurology company founded by ALS advocates Brian Wallach and Sandra Abrevaya. It delivers specialty care, care coordination, caregiver support, and clinical-trial navigation for people living with neurodegenerative diseases across all 50 states.
Primary product
Virtual-first specialty neurology care platform for neurodegenerative diseases
Founded
2019
Headquarters
Chicago, Illinois, United States
Team size
70-80
Work style
Remote
Industry
Hospitals and Health Care
Sub-industry
Virtual neurology / telehealth for neurodegenerative disease
Offices